Loading clinical trials...
Loading clinical trials...
Safety and Efficacy Study of Anyu Peibo in the Treatment of Major Depressive Disorder(MDD): a Ⅱb Stratified Randomized, Double-Blind, Placebo-Paralleled, Multicenter Clinical Trial
Conditions
Interventions
Anyu Peibo
Placebo
Locations
8
China
Beijing Anding Hospital，Capital Medical University
Beijing, Beijing Municipality, China
Beijing HuiLongGuan Hospital
Beijing, Beijing Municipality, China
Wuhan Mental Health Center
Wuhan, Hubei, China
Jiangxi Mental Hospital
Nanchang, Jiangxi, China
Brain Hospital of Jilin Province
Siping, Jilin, China
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
Start Date
June 30, 2017
Primary Completion Date
October 5, 2018
Completion Date
November 29, 2018
Last Updated
January 23, 2019
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT05017311
Lead Sponsor
Shanghai Mental Health Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions